229 related articles for article (PubMed ID: 17069522)
1. Mathematical modeling of cancer progression and response to chemotherapy.
Sanga S; Sinek JP; Frieboes HB; Ferrari M; Fruehauf JP; Cristini V
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1361-76. PubMed ID: 17069522
[TBL] [Abstract][Full Text] [Related]
2. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
Ribeiro D; Pinto JM
Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis testing via integrated computer modeling and digital fluorescence microscopy.
Gardner MK; Odde DJ; Bloom K
Methods; 2007 Feb; 41(2):232-7. PubMed ID: 17189865
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
[TBL] [Abstract][Full Text] [Related]
5. Mathematical modelling for the assessment of the effect of drug application delays in metronomic chemotherapy of cancer due to physiological constraints.
Mukherjee A; Majumder D
Biosystems; 2008 Jan; 91(1):108-16. PubMed ID: 17889991
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Mathematical and numerical analysis for a model of growing metastatic tumors.
Barbolosi D; Benabdallah A; Hubert F; Verga F
Math Biosci; 2009 Mar; 218(1):1-14. PubMed ID: 19121638
[TBL] [Abstract][Full Text] [Related]
8. The genetic origin of drug resistance in neoplasms: implications for systemic therapy.
Goldie JH; Coldman AJ
Cancer Res; 1984 Sep; 44(9):3643-53. PubMed ID: 6744284
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls.
de Pillis LG; Gu W; Fister KR; Head T; Maples K; Murugan A; Neal T; Yoshida K
Math Biosci; 2007 Sep; 209(1):292-315. PubMed ID: 17306310
[TBL] [Abstract][Full Text] [Related]
10. Molecular-targeted therapies: lessons from years of clinical development.
Rosa DD; Ismael G; Lago LD; Awada A
Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
[TBL] [Abstract][Full Text] [Related]
11. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?
Kraljevic S; Sedic M; Scott M; Gehrig P; Schlapbach R; Pavelic K
Cancer Treat Rev; 2006 Dec; 32(8):619-29. PubMed ID: 17069979
[TBL] [Abstract][Full Text] [Related]
12. Mathematical modeling for novel cancer drug discovery and development.
Zhang P; Brusic V
Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
[TBL] [Abstract][Full Text] [Related]
13. [Genomic markers and anticancer chemotherapy].
Nishiyama M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
[TBL] [Abstract][Full Text] [Related]
14. How can systems pathology help us personalize cancer therapy?
Faratian D; Langdon SP; Harrison DJ
Discov Med; 2009 Aug; 8(41):81-6. PubMed ID: 19788873
[TBL] [Abstract][Full Text] [Related]
15. A data integration approach for cell cycle analysis oriented to model simulation in systems biology.
Alfieri R; Merelli I; Mosca E; Milanesi L
BMC Syst Biol; 2007 Aug; 1():35. PubMed ID: 17678529
[TBL] [Abstract][Full Text] [Related]
16. Mathematical models of cancer stem cells.
Michor F
J Clin Oncol; 2008 Jun; 26(17):2854-61. PubMed ID: 18539964
[TBL] [Abstract][Full Text] [Related]
17. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
Ledzewicz U; Schättler H
Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
[TBL] [Abstract][Full Text] [Related]
18. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
19. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
20. Integration of cell biology, pharmacological modeling and statistical analysis: part I: cell biology and PK/PD in the Oncology paradigm.
Ananthakrishnan R; Menon S
Crit Rev Oncol Hematol; 2012 Aug; 83(2):153-69. PubMed ID: 22118941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
